Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 May;47(5):369–371. doi: 10.1136/thx.47.5.369

Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.

P Collard 1, P Weynants 1, C Francis 1, D O Rodenstein 1
PMCID: PMC463753  PMID: 1319088

Abstract

BACKGROUND: Relapse of small cell lung cancer is not usually treated with further chemotherapy as results are considered to be disappointing. METHODS AND RESULTS: Six patients with relapse of small cell lung cancer after a complete initial response and remission of more than one year responded to repeat treatment with the initial chemotherapy comprising carboplatin, etoposide, and epirubicin. The second remission ranged from six months to more than 15 months. CONCLUSION: In patients with a relapse of small cell lung cancer after a complete initial response and prolonged remission retreatment with the initial combination chemotherapy cannot be dismissed and requires further study.

Full text

PDF
369

Images in this article

370Image
on p.370
370Image
on p.370
370Image
on p.370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanian R., Gehan E., Haut A., Saiki J., Weick J. Unmaintained remissions in multiple myeloma. Blood. 1978 Jun;51(6):1005–1011. [PubMed] [Google Scholar]
  2. Batist G., Ihde D. C., Zabell A., Lichter A. S., Veach S. R., Cohen M. H., Carney D. N., Bunn P. A. Small-cell carcinoma of lung: reinduction therapy after late relapse. Ann Intern Med. 1983 Apr;98(4):472–474. doi: 10.7326/0003-4819-98-4-472. [DOI] [PubMed] [Google Scholar]
  3. Buzdar A. U., Legha S. S., Hortobagyi G. N., Yap H. Y., Wiseman C. L., Distefano A., Schell F. C., Barnes B. C., Campos L. T., Blumenschein G. R. Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens. Cancer. 1981 Jun 15;47(12):2798–2802. doi: 10.1002/1097-0142(19810615)47:12<2798::aid-cncr2820471207>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  4. Byrne M. J., van Hazel G., Trotter J., Cameron F., Shepherd J., Cassidy B., Gebski V. Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial. Br J Cancer. 1989 Sep;60(3):413–418. doi: 10.1038/bjc.1989.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crompton G. Small cell lung cancer. BMJ. 1990 Jan 27;300(6719):209–210. doi: 10.1136/bmj.300.6719.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fisher R. I., DeVita V. T., Hubbard S. P., Simon R., Young R. C. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med. 1979 May;90(5):761–763. doi: 10.7326/0003-4819-90-5-761. [DOI] [PubMed] [Google Scholar]
  7. Giaccone G., Ferrati P., Donadio M., Testore F., Calciati A. Reinduction chemotherapy in small cell lung cancer. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1697–1699. doi: 10.1016/0277-5379(87)90452-4. [DOI] [PubMed] [Google Scholar]
  8. Humblet Y., Weynants P., Bosly A., Majois F., Duprez P., Francis C., Beauduin M., Machiels J., Gailly C., Delaunois L. Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group. Med Oncol Tumor Pharmacother. 1989;6(3):207–212. doi: 10.1007/BF02985192. [DOI] [PubMed] [Google Scholar]
  9. Leonard R. C. Small cell lung cancer. Br J Cancer. 1989 Apr;59(4):487–490. doi: 10.1038/bjc.1989.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Postmus P. E., Berendsen H. H., van Zandwijk N., Splinter T. A., Burghouts J. T., Bakker W. Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1409–1411. doi: 10.1016/0277-5379(87)90128-3. [DOI] [PubMed] [Google Scholar]
  11. Seltzer V., Vogl S., Kaplan B. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent. Gynecol Oncol. 1985 Jun;21(2):167–176. doi: 10.1016/0090-8258(85)90249-5. [DOI] [PubMed] [Google Scholar]
  12. Spiro S. G., Souhami R. L. Duration of chemotherapy in small cell lung cancer. Thorax. 1990 Jan;45(1):1–2. doi: 10.1136/thx.45.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Spiro S. G., Souhami R. L., Geddes D. M., Ash C. M., Quinn H., Harper P. G., Tobias J. S., Partridge M., Eraut D. Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer. 1989 Apr;59(4):578–583. doi: 10.1038/bjc.1989.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wendt A. G., Jones S. E., Salmon S. E. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):269–273. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES